INS and metabolic dysfunction-associated steatotic liver disease: Insulin can increase lipase activity, which increases triglyceride uptake by adipose tissue, promoting fat storage in the liver, and leading to NAFLD and excessive lipid deposition, further exacerbating insulin resistance (9).